Jeffrey Zabinski, MD
On the web
Overview
Jeffrey Zabinski, MD, MSW, is the Director of Interventional Psychiatry at Columbia University Irving Medical Center and an Associate Program Director in the adult psychiatry residency. He specializes in psychotherapy and psychopharmacology for patients with treatment-resistant and medically complex psychiatric illness.
Dr. Zabinski helped launch and expand Columbia’s intranasal esketamine and IV ketamine services and previously served as the inaugural liaison to neurology and neurosurgery. His clinical and scholarly interests include neuropsychiatry, medical ethics, and interventional psychiatry. He has also completed formal training in psychedelic psychotherapy, which informs his integrative, patient-centered approach.
His academic background includes a BSE in biomedical engineering, an MA in bioethics, and an MSW in clinical social work. He completed his residency at Johns Hopkins Hospital—where he served as Chief Resident—followed by a fellowship in consultation-liaison psychiatry at NYU before joining the Columbia faculty.
Areas of Expertise / Conditions Treated
- Anxiety Disorders
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Electroconvulsive Therapy (ECT)
- LGBTQ Mental Health
- Mood Disorders
- Obsessive Compulsive Disorder (OCD)
- Post Traumatic Stress Disorder (PTSD)
- Psychopharmacology
- Psychotherapy
- Transcranial Magnetic Stimulation (TMS)
Academic Appointments
- Assistant Professor of Psychiatry at the Columbia University Medical Center
Administrative Titles
- Associate Program Director, Adult Psychiatry Residency
- Director of Interventional Psychiatry
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- POS
- PPO
- Student Health
CHP Student Health
- CHP-NYU
Medicare
- Railroad
- Traditional Medicare
UnitedHealthcare
- Behavioral Health (Columbia University Employee Plan)
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- MD, 2015 Wright State University, Boonshoft School of Medicine
- Residency: 2019 Psychiatry, The Johns Hopkins University School of Medicine
- Fellowship: 2020 Psychiatry, NYU Langone Medical Center & School of Medicine
Board Certifications
- Psychiatry
Research
Selected Publications
Verne, Z. J., Gukasyan, N., & Zabinski, J. (2025). Ketamine and the Consequences of Positive Psychedelic Exceptionalism. The American Journal of Bioethics, 25(1), 115-117.
Verne, Z., & Zabinski, J. (2024). How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety? AMA Journal of Ethics, 26(11), 868-874.
Austelle, C. W., Ehrie, J., & Zabinski, J. S. (2024). Hope in the Face of “Futility”: Considering the Full Scope of Psychiatric Treatment Options. AJOB neuroscience, 15(1), 59-61.
Verne, Z. J., & Zabinski, J. S. (2023). Changes in Personality, Mood, and Behavior with TMS and ECT: Current Knowledge and Challenges. AJOB neuroscience, 14(3), 325-327.
Lieberman, O. J., Lee, S., & Zabinski, J. (2023). Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium. Alzheimer's & Dementia, 19(5), 1742-1751.
Mishkin, A. D., Zabinski, J. S., Holt, G., & Appelbaum, P. S. (2023). Ensuring privacy in telemedicine: Ethical and clinical challenges. Journal of Telemedicine and Telecare, 29(3), 217-221.
Holt, G., Zabinski, J., & Sampson-Mills, T. (2023). Materialized Oppression in Inpatient Psychiatric Unit Design. The American Journal of Bioethics, 23(4), 43-45.
Neufeld, K. J., Leoutsakos, J. M. S., Yan, H., Lin, S., Zabinski, J. S., Dinglas, V. D., Hosey, M. M., Parker, A. M., Hopkins, R. O., & Needham, D. M. (2020). Fatigue symptoms during the first year following ARDS. Chest, 158(3), 999-1007.